Eylea Safety Versus Ease Of Reimbursement Frames Advisory Cmte. Discussion Of Dosing
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA panel unanimously backs the wet age-related macular degeneration therapy with support for a bi-monthly dosing scheme, but monthly schedule may be included as well.